Paperpal Prime Logo

Ophthalmology and Therapy : Impact Factor & More

eISSN: 2193-6528pISSN: 2193-8245
JournalOpen Access

Key Metrics

CiteScore
4.8
Impact Factor
< 5
SJR
Q1Ophthalmology
SNIP
1.7
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Ophthalmology and Therapy

Ophthalmology and Therapy Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher SPRINGER INT PUBL AG
Language English
Frequency Semi-annual
Article Processing ChargesEUR 5500 | USD 6850 | GBP 4700
Publication Time6
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
FrequencySemi-annual
Publication Start Year2012
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 6
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY-NC
OA statementVisit website
View less

Planning to publish in Ophthalmology and Therapy ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Ophthalmology and Therapy

Early Effect of Intravitreal Faricimab on Hard Exudates in Diabetic Macular Oedema.
  • 8 Aug 2026
  • Ophthalmology and therapy
Macular Pigment Changes in Patients with Diabetes Mellitus and Without Diabetic Retinopathy.
  • 8 Aug 2026
  • Ophthalmology and therapy
Visual Outcomes and Patient-Reported Dysphotopsia After PanOptix and PanOptix Toric Implantation Stratified by Preoperative Chord Mu: A Prospective Observational Cohort Study.
  • 8 Aug 2026
  • Ophthalmology and therapy
Paediatric Keratoconus: An ERN-EYE Clinical Consensus Statement on Diagnosis, Treatment and Follow-Up Care.
  • 31 Jul 2026
  • Ophthalmology and therapy
Real-World Outcomes of Faricimab for Polypoidal Choroidal Vasculopathy in a Multi-ethnic Cohort: A 12-Month Retrospective Study.
  • 27 Jul 2026
  • Ophthalmology and therapy
Photodynamic Therapy in Central Serous Chorioretinopathy: Treatment Timing, Anatomical Response, and Recurrence in a Large Real-World Cohort.
  • 27 Jul 2026
  • Ophthalmology and therapy
Early Effect of Intravitreal Faricimab on Hard Exudates in Diabetic Macular Oedema.
  • 8 Aug 2026
  • Ophthalmology and therapy
Macular Pigment Changes in Patients with Diabetes Mellitus and Without Diabetic Retinopathy.
  • 8 Aug 2026
  • Ophthalmology and therapy
Visual Outcomes and Patient-Reported Dysphotopsia After PanOptix and PanOptix Toric Implantation Stratified by Preoperative Chord Mu: A Prospective Observational Cohort Study.
  • 8 Aug 2026
  • Ophthalmology and therapy
Paediatric Keratoconus: An ERN-EYE Clinical Consensus Statement on Diagnosis, Treatment and Follow-Up Care.
  • 31 Jul 2026
  • Ophthalmology and therapy
Real-World Outcomes of Faricimab for Polypoidal Choroidal Vasculopathy in a Multi-ethnic Cohort: A 12-Month Retrospective Study.
  • 27 Jul 2026
  • Ophthalmology and therapy
Photodynamic Therapy in Central Serous Chorioretinopathy: Treatment Timing, Anatomical Response, and Recurrence in a Large Real-World Cohort.
  • 27 Jul 2026
  • Ophthalmology and therapy

FAQs on Ophthalmology and Therapy